Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. Radiol Oncol [Internet]. 2023 Sep. 11 [cited 2026 Sep. 24];57(3):405-10. Available from: https://radioloncol.com/index.php/ro/article/view/4122